BMC Cancer

Article	Citations
Clinical effects of curcumin in enhancing cancer therapy: A systematic review	201
Gut microbiome and its role in colorectal cancer	121
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protoc	87
Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis	83
Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program	80
Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial	78
Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling	73
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma	73
Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma	72
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)	72
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients	71
Association between heavy metals and colon cancer: an ecological study based on geographical information systems in North-Eastern Iran	70
Robot-assisted thoracic surgery versus video-assisted thoracic surgery for lung lobectomy or segmentectomy in patients with non-small cell lung cancer: a meta-analysis	68
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma	67
Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis	65
Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up	64
Exosomal circEIF3K from cancer-associated fibroblast promotes colorectal cancer (CRC) progression via miR-214/PD-L1 axis	64
Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis	60
Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis	60
Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells	59
PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial	58
Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019	57
LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target	56
Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody	54
Prognosis of pregnancy-associated breast cancer: a meta-analysis	54

Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis	52
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer	52
Fusobacterium nucleatum and oral cancer: a critical review	51
Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study	51
Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: a propensity score analysis	51
Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer	50
Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review	48
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results	48
A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma	48
Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer	47
Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial)	47
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications	47
Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population	45
Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status	45
A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma	45
Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database	44
Impact of modified short-term fasting and its combination with a fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in cancer patients - a con	44
Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study	43
A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer	43
Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma	42
PTEN loss correlates with T cell exclusion across human cancers	42
Effectiveness of clinical breast examination as a ‘stand-alone’ screening modality: an overview of systematic reviews	42
Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years	41
Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) – a phase II prospective randomized multicenter trial (NOA-	41
Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a p	41
Limb salvage versus amputation in patients with osteosarcoma of the extremities: an update in the modern era using the National Cancer Database	41
The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma	40
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review	40
Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis	40
A scientometric analysis of neuroblastoma research	40
Designing an exercise intervention for adult survivors of childhood cancers	40
A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery	40
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13–01)	40
Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer	39
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer	39
The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophagea	38
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma	38
Development and validation of a five-immune gene prognostic risk model in colon cancer	38
Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis	38
Cancer incidence and mortality trends in France over 1990–2018 for solid tumors: the sex gap is narrowing	38
PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma	38
Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis	37
CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer	37
Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea	37
Homologous recombination proficiency in ovarian and breast cancer patients	37
A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC)	37
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous reco	37
The prognostic value of IDO expression in solid tumors: a systematic review and meta-analysis	36
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screeni	35
Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) rando	35

Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients	35
Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affe	35
Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study	34
Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study	34
Nutritional status according to the mini nutritional assessment (MNA)® as potential prognostic factor for health and treatment outcomes in patients with cancer – a systematic review	34
RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint	34
Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients	34
Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study	33
Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis	33
Machine-learning based MRI radiomics models for early detection of radiation-induced brain injury in nasopharyngeal carcinoma	33
A novel pancreatic tumour and stellate cell 3D co-culture spheroid model	33
CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model	33
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)	33
Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma	33
Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma	33
Recent incidence trend of elderly patients with glioblastoma in the United States, 2000–2017	33
A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis	33
ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors	33
The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study	33
Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States	32
The patient-level effect of the cost of Cancer care – financial burden in German Cancer patients	32
A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer	32
The mixed blessing of AMPK signaling in Cancer treatments	32
Impact of the comprehensive geriatric assessment on treatment decision in geriatric oncology	32
Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial	32
The impact of high-intensity interval training exercise on breast cancer survivors: a pilot study to explore fitness, cardiac regulation and biomarkers of the stress systems	31
A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma	31
Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma	31
High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer	31
Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review	31
Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study	31
SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target	31
A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer	30
Risk and prognostic factors of breast cancer with liver metastases	30
Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice	30
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients	30
Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis	30
Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis	30
Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response	30
YB-1 transferred by gastric cancer exosomes promotes angiogenesis via enhancing the expression of angiogenic factors in vascular endothelial cells	30
The psychosocial determinants of quality of life in breast cancer survivors: a scoping review	30
Long-term trends in colorectal cancer: incidence, localization, and presentation	29
The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis	29
Pembrolizumab plus lenvatinib with or without hepatic arterial infusion chemotherapy in selected populations of patients with treatment-naive unresectable hepatocellular carcinoma exhibiting PD-L1 sta	29
Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma	29
Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer	29
A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma	29
Neutral polysaccharide from Panax notoginseng enhanced cyclophosphamide antitumor efficacy in hepatoma H22-bearing mice	29
Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells	29
Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study	29
Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression	29
The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma	29
Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation	28
Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer	28
Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers	28
Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer	28
Immune characterization of metastatic colorectal cancer patients post reovirus administration	28
EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer	28
Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer	28
Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study	28
Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study	28
The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis	27
Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast	27
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker	27
Tumor-associated tissue eosinophilia predicts favorable clinical outcome in solid tumors: a meta-analysis	27
High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia	27
Raised CA19–9 and CEA have prognostic relevance in gallbladder carcinoma	27
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertroph	27
Primary effusion lymphoma occurring in the setting of transplanted patients: a systematic review of a rare, life-threatening post-transplantation occurrence	27
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial	27
Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders’ views on a low-risk breast screening pathway	27
Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy	27
Supporting the patients with advanced cancer and their family caregivers: what are their palliative care needs?	26
Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study	26
Causal relationship between genetically predicted depression and cancer risk: a two-sample bi-directional mendelian randomization	26
MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma	26
Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors	26
Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial	26
The implementation of colorectal cancer screening interventions in low-and middle-income countries: a scoping review	26
Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma	26

Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment	26
Genetic alterations and their therapeutic implications in epithelial ovarian cancer	26
Current lung cancer screening guidelines may miss high-risk population: a real-world study	26
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells	26
Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approach	26
Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer	26
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label pha	25
An M0 macrophage-related prognostic model for hepatocellular carcinoma	25
Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma	25
“Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study”	25
The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma	25
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9	25
Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer	25
Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer	25
RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers	25
MiR-16-5p suppresses breast cancer proliferation by targeting ANLN	25
Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway	25
MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours	25
Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis	25
CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy	25
A 10-year bibliometric analysis of osteosarcoma and cure from 2010 to 2019	25
Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients	25
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma	25
A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma	24
Independence of HIF1a and androgen signaling pathways in prostate cancer	24
Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis	24
Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma	24
Microbiome composition indicate dysbiosis and lower richness in tumor breast tissues compared to healthy adjacent paired tissue, within the same women	24
Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota	24
The role of the bacterial microbiome in the treatment of cancer	24
Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis	24
Anti-proliferative activity of A. Oxyphylla and its bioactive constituent nootkatone in colorectal cancer cells	24
Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer	24
Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck	24
The effects of combination treatments on drug resistance in chronic myeloid leukaemia: an evaluation of the tyrosine kinase inhibitors axitinib and asciminib	24
Pan-cancer analysis identifies BIRC5 as a prognostic biomarker	24
A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers	24
Quality of life and psychological distress during cancer: a prospective observational study involving young breast cancer female patients	24
Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer	24
A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates	24
The benefits and acceptability of virtual reality interventions for women with metastatic breast cancer in their homes; a pilot randomised trial	24
Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma	24
HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells	23
Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis	23
Effect of microwave ablation treatment of hepatic malignancies on serum cytokine levels	23
A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study	23
Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway	23
Head and neck cancer patients’ preferences for individualized prognostic information: a focus group study	23
COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells	23
Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1	23
Temozolomide sensitivity of malignant glioma cell lines – a systematic review assessing consistencies between in vitro studies	23
A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database	23
Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study	23
Feasibility and safety of exercise training and nutritional support prior to haematopoietic stem cell transplantation in patients with haematologic malignancies	23
Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia	23
Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospe	23
Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis	23
The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies	23
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer	23
Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China	23
Cervical cancer screening in rural Ethiopia: a cross- sectional knowledge, attitude and practice study	23
Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer	23
Cancer cases and deaths attributable to lifestyle risk factors in Chile	23
GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colo	23
Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma	23
Oligosaccharides increase the genotoxic effect of colibactin produced by pks+ Escherichia coli strains	23
Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes	22
Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion	22
Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients	22
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice	22
The majority of β-catenin mutations in colorectal cancer is homozygous	22
Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study	22
Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review	22
Feasibility of a multimodal exercise, nutrition, and palliative care intervention in advanced lung cancer	22
Clinical significance of the cachexia index in patients with small cell lung cancer	22
Breast cancer mammospheres secrete Adrenomedullin to induce lipolysis and browning of adjacent adipocytes	22
Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis	22
Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer	22
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab	22
Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study	22
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial	22
Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study	22
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019	22
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies	22
Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients	22
Attention to principles of exercise training: an updated systematic review of randomized controlled trials in cancers other than breast and prostate	22
AHRR methylation in heavy smokers: associations with smoking, lung cancer risk, and lung cancer mortality	22
Fibroadenoma versus phyllodes tumor: a vexing problem revisited!	22
The prognostic values of m6A RNA methylation regulators in uveal melanoma	22
CT Scans and Cancer Risks: A Systematic Review and Dose-response Meta-analysis	22
The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants	22
Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer	22
Efficient mutation screening for cervical cancers from circulating tumor DNA in blood	22
The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis	22
Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer	22